Skip to main content
Premium Trial:

Request an Annual Quote

Digital Gene Technologies Closes $22 M Placement

Premium

L

A JOLLA, Calif.--Privately held Digital Gene Technologies said it would use $22 million that it secured in a recent private placement to accelerate deployment of its automated assay technology and to advance its bioinformatics development.

Digital Gene’s Total Gene Expression Analysis product is a patented method of identifying and determining the concentration of genes active in a sample cell or tissue.

The company said it self-managed the oversubscribed third round of financing, which brought in capital from current shareholders and new investors. Since its inception in 1995 Digital Gene has raised $34 million.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.